GUFIC BIOSCIENCES
Quarterly Results Analysis [Mar2025]
GUFIC BIOSCIENCES Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 Audited |
Dec2023 UnAudited |
Sep2023 UnAudited |
---|---|---|---|---|---|---|---|
Revenues | ₹205 Cr | ₹208 Cr | ₹204 Cr | ₹203 Cr | ₹195 Cr | ₹202 Cr | ₹215 Cr |
Expenses | ₹179 Cr | ₹174 Cr | ₹166 Cr | ₹167 Cr | ₹161 Cr | ₹165 Cr | ₹176 Cr |
Operating Income | ₹26 Cr | ₹34 Cr | ₹39 Cr | ₹36 Cr | ₹34 Cr | ₹36 Cr | ₹39 Cr |
Other Income | ₹0 Cr | ₹2 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹8 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr |
Depreciation | ₹8 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
Profit Before Tax | ₹11 Cr | ₹26 Cr | ₹29 Cr | ₹28 Cr | ₹27 Cr | ₹30 Cr | ₹31 Cr |
Profit After Tax | ₹8 Cr | ₹19 Cr | ₹22 Cr | ₹21 Cr | ₹20 Cr | ₹22 Cr | ₹23 Cr |
EPS | ₹0.77 | ₹1.93 | ₹2.17 | ₹2.08 | ₹2.00 | ₹2.22 | ₹2.39 |
Industry Peers & Returns | 1W | 1M | 1Y |
GUFIC BIOSCIENCES | 0.3% | -5.6% | -1.5% |
SUN PHARMACEUTICAL INDUSTRIES | -0.6% | 0.8% | 10.5% |
DIVIS LABORATORIES | 3.1% | 3.8% | 49.2% |
CIPLA | 0.4% | 2.5% | 1.2% |
TORRENT PHARMACEUTICALS | -0.2% | 6.4% | 20.5% |
DR REDDYS LABORATORIES | -0.6% | 3.3% | 0.1% |
MANKIND PHARMA | 1.3% | 0.7% | 10.4% |
ZYDUS LIFESCIENCES | 1.8% | 7.3% | -6.7% |
LUPIN | 1% | 0.7% | 21.7% |
GUFIC BIOSCIENCES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -1.33 % |
Y-o-Y | 5.14 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹205 Cr | -1.33 | |
Dec2024 | ₹208 Cr | 1.77 | |
Sep2024 | ₹204 Cr | 0.67 | |
Jun2024 | ₹203 Cr | 4.01 | |
Mar2024 | ₹195 Cr | -3.36 | |
Dec2023 | ₹202 Cr | -6.09 | |
Sep2023 | ₹215 Cr | - |
GUFIC BIOSCIENCES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -22.26 % |
Y-o-Y | -22.95 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹26 Cr | -22.26 | |
Dec2024 | ₹34 Cr | -12.15 | |
Sep2024 | ₹39 Cr | 7.93 | |
Jun2024 | ₹36 Cr | 4.53 | |
Mar2024 | ₹34 Cr | -6.11 | |
Dec2023 | ₹36 Cr | -7.40 | |
Sep2023 | ₹39 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -21.25 % |
Y-o-Y | -26.72 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 12.86% | -21.25 | |
Dec2024 | 16.33% | -13.64 | |
Sep2024 | 18.91% | 7.20 | |
Jun2024 | 17.64% | 0.51 | |
Mar2024 | 17.55% | -2.88 | |
Dec2023 | 18.07% | -1.36 | |
Sep2023 | 18.32% | - |
GUFIC BIOSCIENCES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -60.01 % |
Y-o-Y | -61.49 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹8 Cr | -60.01 | |
Dec2024 | ₹19 Cr | -11.31 | |
Sep2024 | ₹22 Cr | 4.37 | |
Jun2024 | ₹21 Cr | 4.04 | |
Mar2024 | ₹20 Cr | -9.93 | |
Dec2023 | ₹22 Cr | -4.11 | |
Sep2023 | ₹23 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -59.42 % |
Y-o-Y | -63.33 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 3.77 % | -59.42 | |
Dec2024 | 9.29 % | -12.85 | |
Sep2024 | 10.66 % | 3.70 | |
Jun2024 | 10.28 % | 0.00 | |
Mar2024 | 10.28 % | -6.80 | |
Dec2023 | 11.03 % | 2.13 | |
Sep2023 | 10.8 % | - |
GUFIC BIOSCIENCES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -60.10 % |
Y-o-Y | -61.50 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹0.77 | -60.10 | |
Dec2024 | ₹1.93 | -11.06 | |
Sep2024 | ₹2.17 | 4.33 | |
Jun2024 | ₹2.08 | 4.00 | |
Mar2024 | ₹2 | -9.91 | |
Dec2023 | ₹2.22 | -7.11 | |
Sep2023 | ₹2.39 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD